You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Peptide Receptor Radionuclide Therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors, Gastro Entero Pancreatic Neuroendocrine Tumors Trial in Meldola, Milan (28 GBq 177Lu-DOTATATE, 22 GBq

Active, not recruiting
  • Neuroendocrine Tumors
  • Gastro Entero Pancreatic Neuroendocrine Tumors
  • 28 GBq 177Lu-DOTATATE
  • 22 GBq 177Lu-DOTATATE
  • Meldola, FC, Italy
  • +1 more
Feb 25, 2021

Neuroendocrine Tumors, Paraganglioma, Pheochromocytoma Trial (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • (no location specified)
Sep 13, 2023

Neuroendocrine Tumor, Liver Metastases, Neuroendocrine Gastroenteropancreatic Tumour Trial in France (Positron emission

Recruiting
  • Neuroendocrine Tumor
  • +2 more
  • Positron emission tomography computed tomography (PET/CT) with Intra-hepatic (IAH) injection
  • +3 more
  • Bordeaux, France
  • +3 more
Nov 18, 2021

Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Bourdeaux, France
  • +24 more
Jun 23, 2023

Neuroendocrine Tumor Trial in San Francisco (90Y-DOTA-TOC, 68Ga-DOTA-TOC)

Completed
  • Neuroendocrine Tumor
  • San Francisco, California
    University of California, San Francisco
Jul 1, 2020

Meningioma Trial in Sydney (Cu-64 SARTATE and Cu-67 SARTATE)

Completed
  • Meningioma
  • Cu-64 SARTATE and Cu-67 SARTATE
  • Sydney, New South Wales, Australia
    Royal North Shore Hospital
Apr 16, 2020

Neuroendocrine Tumors, Carcinoid Tumor, Carcinoma, Neuroendocrine Trial in Quebec City (177Lu-Octreotate)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Quebec City, Quebec, Canada
    CHU de Québec - Université Laval
Jul 15, 2020

Hepatocellular Carcinoma Trial in Birmingham ([68Ga]DOTATATE-PET/MRI)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Birmingham, Alabama
    University of Alabama at Birmingham Medical Center
Dec 16, 2022

Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • 90Y-DOTA tyr3-Octreotide
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 6, 2022

Neuroendocrine Tumors Trial in Warszawa (90Y-DOTATATE, (177Lu-DOTAOTyr3)Octreotate, 90Y DOTATATE and 177Lu DOTATATE (mix each of

Unknown status
  • Neuroendocrine Tumors
  • Warszawa, Poland
    Centrum Diagnostyczno-Lecznicze Gammed
Mar 31, 2020

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • Myocardial Infarction
  • PCI
  • Naples, Italy
    Celestino Sardu
Aug 31, 2023

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Neuroendocrine Tumors Trial (Lutathera)

Not yet recruiting
  • Neuroendocrine Tumors
  • (no location specified)
Aug 23, 2022

Prostatic Tumors, Castration-Resistant Trial (64Cu-SAR-BBN, 67Cu-SAR-BBN)

Not yet recruiting
  • Prostatic Neoplasms
  • Castration-Resistant
  • (no location specified)
Dec 1, 2022

Kidney Transplant Recipients Trial in Toronto (Dapagliflozin 10 MG, Semaglutide, 1.0 mg/mL)

Not yet recruiting
  • Kidney Transplant Recipients
  • Dapagliflozin 10 MG
  • Semaglutide, 1.0 mg/mL
  • Toronto, Ontario, Canada
    Toronto General Hospital
Jul 6, 2023

Neuroendocrine Tumors Trial in Bogota ([177Lu] DOTA-TATE)

Completed
  • Neuroendocrine Tumors
  • [177Lu] DOTA-TATE
  • Bogota, Cundinamarca, Colombia
    Instituto Nacional de Cancerología
Nov 12, 2019

Meningioma Trial in Vandœuvre-lès-Nancy (Everolimus)

Not yet recruiting
  • Meningioma
  • Vandœuvre-lès-Nancy, Grand Est, France
  • +1 more
Nov 8, 2023

Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)

Not yet recruiting
  • Metastatic Midgut Neuroendocrine Tumor
  • Unresectable Midgut Neuroendocrine Tumor
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Mar 16, 2023

Breast Cancer Trial ([68Ga]Ga-NeoB, [177Lu]Lu-NeoB, Ribociclib)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
May 22, 2023

Platinum Sensitive Ovarian Cancer, Ovarian Cancer Trial in United States (FRa peptide plus Adjuvant (GM-CSF), Adjuvant (GM-CSF)

Terminated
Has Results
  • Platinum Sensitive Ovarian Cancer
  • Ovarian Cancer
  • FRα peptide plus Adjuvant (GM-CSF)
  • Adjuvant (GM-CSF) Alone
  • Birmingham, Alabama
  • +17 more
Nov 21, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Neuroendocrine Neoplasia's (NENs), Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) Trial in Basel (161Tb-DOTA-LM3,

Not yet recruiting
  • Neuroendocrine Neoplasia's (NENs)
  • Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
  • Basel, Switzerland
    Division of Nuclear Medicine, University Hospital Basel
Apr 27, 2022

Breast Cancer Trial in Durham (ESR1 peptide vaccine)

Recruiting
  • Breast Cancer
  • ESR1 peptide vaccine
  • Durham, North Carolina
    Duke University Medical Center
Sep 13, 2021

Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

Recruiting
  • Neuroendocrine Tumors
  • Innsbruck, Austria
  • +2 more
May 12, 2023

Development of New Personalised 3D Preclinical Models of

Recruiting
  • Pancreatic Neuroendocrine Tumor
    • Milan, MI, Italy
      IRCCS San Raffele Institute
    Nov 2, 2023